Cargando…

Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B

BACKGROUND: Quantitative hepatitis B core-related antigen (qHBcrAg) has a better correlation with intrahepatic hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) than HBV DNA or hepatitis B e antigen (HBeAg), but data are still lacking for its clinical application. AIM: The aim was to i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chi, Xiu-Mei, Wang, Xiao-Mei, Wang, Zhong-Feng, Wu, Rui-Hong, Gao, Xiu-Zhu, Xu, Hong-Qin, Ding, Yan-Hua, Niu, Jun-Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Retrospective Cohort Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567480/ https://www.ncbi.nlm.nih.gov/pubmed/34790015 http://dx.doi.org/10.3748/wjg.v27.i40.6927

Ejemplares similares

Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B
por: Chen, En-Qiang, et al.
Publicado: (2017)

Correlations between serum hepatitis B core-related antigen and hepatitis B surface antigen in patients with hepatitis B cirrhosis and a hepatitis B virus-DNA-negative status: a retrospective study
por: Xu, Baiguo, et al.
Publicado: (2022)

Hepatitis D virus dual-infection among Chinese hepatitis B patient related to hepatitis B surface antigen, hepatitis B virus DNA and age
por: Zi, Jun, et al.
Publicado: (2023)

Clinical features of acute hepatitis E super-infections on chronic hepatitis B
por: Chen, Chong, et al.
Publicado: (2016)

Seroconversion of Hepatitis B Virus Surface Antigen in Chronic Hepatitis B Child Treated with Entecavir
por: Li, Dong, et al.
Publicado: (2012)

Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
por: Yim, Sun Young, et al.
Publicado: (2017)

Hepatitis B virus infection in patients with Wilson disease: A large retrospective study
por: Zhou, Hua-Ying, et al.
Publicado: (2023)

On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B
por: Chang, Xiu-Juan, et al.
Publicado: (2019)

Hepatitis B e Antigen Seroconversion Is Related with the Function of Dendritic Cells in Chronic Hepatitis B Virus Infection
por: Lin, Chunjing, et al.
Publicado: (2014)

Seroconversion of Hepatitis B Envelope Antigen (HBeAg) by Entecavir in a Child with Chronic Hepatitis B
por: Hasosah, Mohammed Y., et al.
Publicado: (2012)

On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chronic hepatitis B
por: Gao, Yu-Hua, et al.
Publicado: (2016)

Tenofovir alafenamide significantly increased serum lipid levels compared with entecavir therapy in chronic hepatitis B virus patients
por: Lai, Rui-Min, et al.
Publicado: (2023)

Effect of lifestyle modification on hepatocellular carcinoma incidence and mortality among patients with chronic hepatitis B
por: Park, Yewan, et al.
Publicado: (2023)

Elevated soluble 4-1BB is associated with serum markers of hepatitis B virus in patients with chronic hepatitis B
por: Zhan, Meng-Ru, et al.
Publicado: (2021)

Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis
por: Zhang, Zhan-qing, et al.
Publicado: (2019)

Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada
por: Binka, Mawuena, et al.
Publicado: (2018)

Liquid biopsy for non-invasive assessment of liver injury in hepatitis B patients
por: Xia, Wen-Ying, et al.
Publicado: (2019)

Hepatitis B Core-Related Antigen and New Therapies for Hepatitis B
por: Watanabe, Takehisa, et al.
Publicado: (2021)

Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
por: Inoue, Takako, et al.
Publicado: (2023)

Predictors of inflammatory activity in treatment-naive hepatitis B e-antigen-negative patients with chronic hepatitis B infection
por: Hu, Jianhua, et al.
Publicado: (2020)

Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B
por: Zhang, Zhan-Qing, et al.
Publicado: (2017)

Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B
por: Seto, Wai-Kay, et al.
Publicado: (2012)

Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis
por: Caviglia, Gian Paolo, et al.
Publicado: (2021)

Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy
por: Lin, Tien-Ching, et al.
Publicado: (2018)

The Role of Hepatitis B Core-Related Antigen
por: Inoue, Takako, et al.
Publicado: (2019)

Hepatitis B core-related antigen reflects viral replication and protein production in chronic hepatitis B patients
por: Li, Jun, et al.
Publicado: (2021)

Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication
por: Jiang, Su-Wen, et al.
Publicado: (2023)

Entecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma
por: Mak, Lung-Yi, et al.
Publicado: (2020)

Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study
por: Stasi, Cristina, et al.
Publicado: (2018)

Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b
por: Endo, Daisuke, et al.
Publicado: (2017)

Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B
por: Abayli, Bahri, et al.
Publicado: (2021)

Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B: A Prospective Observational Study
por: Jia, Wei, et al.
Publicado: (2014)

Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy
por: Gök Sargın, Zeynep
Publicado: (2023)

Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus
por: Cao, Xi, et al.
Publicado: (2020)

Predicting hepatitis B e Antigen seroconversion after pregnancy—The SydPregScore
por: Thilakanathan, Cynthuja, et al.
Publicado: (2022)

Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease
por: Tan, You-Wen, et al.
Publicado: (2023)

Prediction for HBsAg seroconversion in children with chronic hepatitis B
por: Zhong, Yan-Wei, et al.
Publicado: (2021)

Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients
por: Lee, Han Ah, et al.
Publicado: (2022)

Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase
por: Tan, You-Wen, et al.
Publicado: (2017)

Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients
por: Broquetas, Teresa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q0msjr55v8i491v8e03tlkd26h